文献速递银屑病与炎症性皮肤病皮肤肿瘤

银屑病与26种癌症风险:丹麦、英国、以色列和台湾的人群队列汇总研究

Psoriasis and risk of 26 cancers: pooled population-based cohort studies from Denmark, England, Israel and Taiwan.
PubMed 文献 · Br J Dermatol · 2026-01-01

结果显示银屑病与总体癌症风险轻度增加相关(pHR 1.08,95%CI 1.04-1.13),在14/26种部位特异性癌症中风险升高。

要点

  • 银屑病患者总体癌症风险轻度升高(pHR 1.08,95%CI 1.04-1.13)
  • 中重度银屑病患者总体癌症风险更高(pHR 1.16,95%CI 1.04-1.28)
  • 关联癌症包括口腔、咽、食管、肝、胰腺、肾、膀胱、角质形成细胞癌及淋巴造血系统肿瘤

核心结论

  • 银屑病与14/26种部位特异性癌症风险增加相关,包括预后较差的肝癌、肺癌和食管癌。

研究设计与样本

  • 在丹麦、英国、以色列和台湾开展基于链接电子健康记录的人群队列研究。
  • 采用Cox回归计算国家特异性风险比,随机效应模型汇总。

主要发现

  • 银屑病与总体癌症风险轻度相关(pHR 1.08,95%CI 1.04-1.13;I2=92.4%)。
  • 调整混杂因素后风险略减弱(pHR 1.05,95%CI 1.01-1.09;I2=81.2%)。
  • 中重度银屑病总体癌症风险略高(pHR 1.16,95%CI 1.04-1.28;I2=92.8%),调整后pHR 1.09(95%CI 1.03-1.15;I2=60.6%)。
  • 口腔癌pHR 1.29(95%CI 1.12-1.47)、咽癌pHR 1.30(95%CI 1.07-1.58)、食管癌pHR 1.17(95%CI 1.03-1.33)。
  • 肝癌pHR 1.53(95%CI 1.33-1.77)、胰腺癌pHR 1.09(95%CI 1.02-1.17)、肾癌pHR 1.19(95%CI 1.11-1.27)、膀胱癌pHR 1.13(95%CI 1.06-1.20)。

关键数值与推荐

  • 银屑病与总体癌症风险相关(pHR 1.08,95%CI 1.04-1.13)。
  • 中重度银屑病总体癌症风险pHR 1.16(95%CI 1.04-1.28);调整后pHR 1.09(95%CI 1.03-1.15)。
  • 肝癌风险pHR 1.53(95%CI 1.33-1.77),霍奇金淋巴瘤pHR 1.56(95%CI 1.16-2.11)。
  • 角质形成细胞癌风险pHR 1.37(95%CI 1.16-1.63)。

临床怎么用

  • 银屑病诊疗中应强化癌症预防策略,尤其关注肝、肺、食管等预后较差癌症。
  • 对中重度银屑病患者可考虑更积极的癌症筛查和监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Psoriasis is a chronic inflammatory skin disease, and the risk of developing cancer has been postulated due to the presence of several plausible underlying mechanisms. Understanding the association between psoriasis and cancer is imperative to the provision of optimal psoriasis care. OBJECTIVES: To examine the risk of developing cancer in individuals with psoriasis. METHODS: Population-based cohort studies were conducted in Denmark, England, Israel and Taiwan through the use of linked electronic health records. Individuals aged at least 18 years with a diagnosis of psoriasis in the country-specific study period were matched with up to six comparators with no record of psoriasis prior to the index date. Country-specific hazard ratios for the risk of cancer development overall and for 26 site-specific cancers between individuals with and without psoriasis were calculated through Cox regression. Country-specific estimates were pooled using random effects modelling. RESULTS: We included 702 022 individuals with psoriasis and 4 185 342 matched comparators. In models implicitly controlled for age, sex and calendar time by matching, there was a small association between psoriasis and cancer overall [pooled HR (pHR) 1.08, 95% confidence interval (CI) 1.04-1.13; I2 = 92.4%]. Adjustment for potential confounding factors resulted in a slight attenuation of risk (pHR 1.05, 95% CI 1.01-1.09; I2 = 81.2%). When restricted to those with moderate-to-severe psoriasis, the risk of cancer overall was slightly higher (pHR 1.16, 95% CI 1.04-1.28; I2 = 92.8%) than in confounder-adjusted models (pHR 1.09, 95% CI 1.03-1.15; I2 = 60.6%). Associations with psoriasis were present for oral cavity (pHR 1.29, 95% CI 1.12-1.47; I2 = 55.4%), pharynx (pHR 1.30, 95% CI 1.07-1.58; I2 = 58.4%), oesophagus (pHR 1.17, 95% CI 1.03-1.33; I2 = 56.6%), liver (pHR 1.53, 95% CI 1.33-1.77; I2 = 75.1%), pancreas (pHR 1.09, 95% CI 1.02-1.17; I2 = 0.0%), kidney (pHR 1.19, 95% CI 1.11-1.27; I2 = 0.0%), bladder (pHR 1.13, 95% CI 1.06-1.20; I2 = 28.7%) and keratinocyte cancers (pHR 1.37, 95% CI 1.16-1.63; I2 = 97.5%), and Hodgkin lymphoma (pHR 1.56, 95% CI 1.16-2.11; I2 = 69.7%), non-Hodgkin lymphoma (pHR 1.16, 95% CI 1.07-1.26; I2 = 35.5%) and leukaemia (pHR 1.18, 95% CI 1.08-1.29; I2 = 41.9%). Site-specific associations generally persisted, with slight risk exacerbations and additional associations for lung and ovarian cancers, when limited to people with moderate-to-severe psoriasis. CONCLUSIONS: Psoriasis was associated with an increased risk of developing 14 of 26 investigated site-specific cancers, including cancers with a poor prognosis, such as liver, lung and oesophageal cancer. Our findings can be used to reinforce cancer prevention strategies in psoriasis care. Psoriasis is a long-term skin condition that affects about 60 million people worldwide. People with psoriasis are at risk of other health problems like joint pain and heart disease. Yet, their risk of developing cancer is not well understood. Other studies have investigated this, but the results have been inconsistent. In this study, we aimed to understand the association between psoriasis and cancer. We examined databases containing health information in Denmark, England, Israel and Taiwan. We compared over 700,000 people with psoriasis and over 4 million people without it. We found that people with psoriasis had a slightly higher risk of developing cancer than people without it. This risk was slightly higher in people with more severe psoriasis. Cancers of the mouth, pharynx (throat), oesophagus, liver, pancreas, kidney and bladder were more likely in people with psoriasis. They were also more likely to develop a particular type of skin cancer. Some blood cancers were also more likely in people with psoriasis. The risk of these cancers was higher in people with more severe psoriasis. Our findings suggest that there is an increased risk of cancer in people with psoriasis. This information should be used to ensure people with psoriasis get the best care.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Trafford AM, Schonmann Y, Chen TC, et al. Psoriasis and risk of 26 cancers: pooled population-based cohort studies from Denmark, England, Israel and Taiwan. Br J Dermatol. 2026. PMID: 41077557. doi:10.1093/bjd/ljaf399

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。